Thyroid recalls
The FDA has published 11 recalls involving Thyroid since 2014. The latest was reported on 23 Sep 2026. Most were for manufacturing (cgmp) deviations. Humco Holding Group has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls11since 2014
Last 12 months2reported
Class I19% of total
Ongoing2latest 23 Sep 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 1 9%Class II 10 91%Class III 0 0%
Why thyroid is recalled
Companies
By year
Ongoing thyroid recalls
2 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS I | Thyroid Tablets, USP, 1/2 Grain (30 mg) recalledThyroid | Vitruvias Therapeutics | Potency & Assay | Nationwide |
| Drug | CLASS II | Thyroid recalled by Specialty Process Labs | Specialty Process Labs | Potency & Assay | Nationwide |
All thyroid recalls, newest first
11 totalShould you stop taking Thyroid?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.